Episodes 16-30 of 160
Navigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Clinician's RoundtableNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
Deciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Clinician's RoundtableDeciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
Proteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Clinician's RoundtableProteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Innovations in IgAN Care: Addressing Challenges with Therapeutic Advances
Clinician's RoundtableInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
Moving Beyond Immunosuppressive Therapy in IgAN
Clinician's RoundtableMoving Beyond Immunosuppressive Therapy in IgAN
Essential Biomarkers for Assessing and Treating IgA Nephropathy
Clinician's RoundtableEssential Biomarkers for Assessing and Treating IgA Nephropathy
- advertisement
IgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
Clinician's RoundtableIgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
Building a Multidisciplinary Approach to IgA Nephropathy Care
Clinician's RoundtableBuilding a Multidisciplinary Approach to IgA Nephropathy Care
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Project Oncology®From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Difelikefalin: Managing CKD-aP for Improved Quality of Life
NephrologyDifelikefalin: Managing CKD-aP for Improved Quality of Life
Exploring a Combination Therapy for CKD and T2D: CONFIDENCE Trial Insights
AudioAbstractsExploring a Combination Therapy for CKD and T2D: CONFIDENCE Trial Insights
IgA Nephropathy Updates: Evolving Guidelines and Practical Strategies
NephrologyIgA Nephropathy Updates: Evolving Guidelines and Practical Strategies
- advertisement
Identifying C3G: Key Diagnostic Considerations and Challenges
On the Frontlines of C3GIdentifying C3G: Key Diagnostic Considerations and Challenges
Transforming C3G Care: New Advances in Targeted Treatment
On the Frontlines of C3GTransforming C3G Care: New Advances in Targeted Treatment
Understanding IgAN: More Than a Benign Disease
Clinician's RoundtableUnderstanding IgAN: More Than a Benign Disease
